Table of Contents: Introduction: FOOD SUPPLEMENTS – A NEW HOPE FOR SCHIZOPHRENIA AND MOOD DISORDERS
(Vladimir Lerner and Chanoch Miodownik; Faculty of Health Sciences, Ben-Gurion Univ. of the Negev, Be’er-Sheva, Israel), pp. 1-4
1. VITAMIN C IN PSYCHIATRY: PAST, PRESENT AND FUTURE
(Joseph Bergman and Anatoly Kreinin; Mental Health Center Tirat Carmel, Technion, Rappaport Faculty of Medicine, Haifa, Israel), pp. 5-25
2. VITAMIN B6 AS TREATMENT OF PSYCHOTROPIC DRUG-INDUCED MOVEMENT DISORDERS AND ADD-ON TREATMENT OF SCHIZOPHRENIA
(Vladimir Lerner and Chanoch Miodownik, Division of Psychiatry, Ministry of Health Be'er Sheva Mental Health Center, Faculty of Health Sciences Ben-Gurion University of the Negev, Be're-Sheva, Israel), pp. 27-56
3. VITAMIN B6 IN TREATING MOOD AND RELATED DISORDERS
(Chanoch Miodownik and Vladimir Lerner, Division of Psychiatry, Ministry of Health Be'er Sheva Mental Health Center, Faculty of Health Sciences Ben-Gurion University of the Negev, Be're-Sheva, Israel), pp. 57-66
4. VITAMIN B12 AND FOLIC ACID IN COGNITIVE AND MENTAL DISORDERS
(Yacov Grinshpun; Soroka Medical Center, Be'er Sheva, Israel; Memory Clinic, Mental Health Center, Be'er Sheva, Israel; Memory Clinic, Mental Health Center, Be'er Sheva, Israel; Faculty of Health Sciences, Ben Gurion Univ. of the Negev, Be'er Sheva, Israel and Tzvi Dwolatzky, Mental Health Center Be'er Sheva, Israel; Memory Clinic, Mental Health Center, Be'er Sheva, Israel; Faculty of Health Sciences, Ben Gurion Univ. of the Negev, Be'er Sheva, Israel), pp. 67-79
5. HOMOCYSTEINE AS A RISK FACTOR IN SCHIZOPHRENIA
(Joseph Levine, Anna Bromberg, and Tzvi Dwolatzky; Division of Psychiatry, Be’er Sheva Mental Health Center; Faculty of Health Sciences, Ben-Gurion Univ. of the Negev, Be’er-Sheva, Israel), pp. 81-96
6. OMEGA-3 IN PSYCHIATRY
(Boris Nemets, Chanoch Miodownik and Vladimir Lerner; Division of Psychiatry, Ministry of Health, Be’er Sheva Mental Health Center,
Faculty of Health Sciences, Ben-Gurion Univ. of the Negev, Be’er-Sheva, Israel), pp. 97-118
7. NOVEL NEUROPROTECTIVE AGENTS FOR SCHIZOPHRENIA: NEUROSTEROIDS, MEMANTINE, BEXAROTENE AND L-THEANINE
(Michael S. Ritsner; Psychiatry Dept. Rappaport Faculty of Medicine, Technion, Israel Inst. of Technology, Haifa, Sha'ar Menashe Mental Health Center, Israel), pp. 119-150
8. MELATONIN AND SCHIZOPHRENIA
(Yoram Barak and Dov Aizenberg; Abarbanel Mental Health Center, Geha Mental Health Center, affiliated with the Sackler Faculty of Medicine, Tel-Aviv Univ., Israel), pp. 151-158
Index |